December 20, 2023 Dear Kevin,Separation and Release Agreement • April 1st, 2024 • Alaunos Therapeutics, Inc. • Pharmaceutical preparations • Texas
This Separation and Release Agreement (“Agreement”) follows up on our recent discussions concerning the termination of your employment with Alaunos Therapeutics, Inc. (the “Company”). To assist you in your transition, the Company is offering you certain transitional benefits in exchange for a mutual, general release of claims and other terms set forth below.
CONSULTING AGREEMENTConsulting Agreement • April 1st, 2024 • Alaunos Therapeutics, Inc. • Pharmaceutical preparations
This Consulting Agreement (this “Agreement”), dated as of February 22, 2024, is made by and between Alaunos Therapeutics, Inc. (the “Company”) and Ferdinand Groenewald (“Consultant”), (together the “Parties”).
CONSULTING AGREEMENTConsulting Agreement • April 1st, 2024 • Alaunos Therapeutics, Inc. • Pharmaceutical preparations
This Consulting Agreement (this “Agreement”), dated as of December 22, 2023, is made by and between Alaunos Therapeutics, Inc. (the “Company”) and Kevin S. Boyle Sr. (“Consultant”).
CONSULTING AGREEMENTConsulting Agreement • April 1st, 2024 • Alaunos Therapeutics, Inc. • Pharmaceutical preparations
This Consulting Agreement (this “Agreement”), dated as of November 14, 2023, is made by and between Alaunos Therapeutics, Inc. (the “Company”) and Melinda Lackey (“Consultant”), (together the “Parties”).
